Breast Cancer Advances in Biology and TherapeuticsHenri Magdelenat John Libbey Eurotext, 1996 - 360 стор. Contributions from leading authors in the field of clinical and biological breast cancer research constitute these three chapters: predisposition to breast cancer, carcinogenesis, and early breast cancer screening and management; tumour biology and prognostic; and therapeutics aspects of breast cancer. 21st Meeting of the International Association for Breast Cancer Research, Paris, 1996. |
Зміст
Psychological aspects of familial breast cancer | 11 |
paradigms for human breast cancer | 19 |
Oncogenes and oncosuppressor genes in the prevention and therapy of breast cancer | 27 |
Molecular basis of human breast epithelial cell transformation | 33 |
intervention | 45 |
Multiple mechanisms of conjugated linoleic acid in mammary cancer prevention | 53 |
n3 polyunsaturated fatty acids and breast cancer | 59 |
Breast cancer screening The scientific basis and the Danish programme | 67 |
Molecular and clinical aspects of metalloproteases in breast cancer | 111 |
Signal transduction of prolactin and cytokine receptors | 131 |
approaches and clinical results | 147 |
The role of angiogenesis in tumour progression of breast cancer | 167 |
Mutiparameter analysis of prognostic factors in breast cancer | 209 |
Clinical circumvention of antioestrogen resistance | 225 |
High dose sequential chemotherapy in poor prognosis breast cancer patients | 245 |
In vivo evaluation of docetaxel Taxotere and vinorelbine Navelbine as single | 265 |
Breast cancer screening The relations with the hospitals and sanitary organisations | 73 |
Breast cancer screening in Canada | 81 |
from research to policy | 87 |
diagnosis strategy and decisional trees | 93 |
Is there now a consensus on the treatment of minimal breast cancer? | 97 |
A short history of drug discovery | 279 |
Immunotherapy of breast cancer using a recombinant Vaccinia virus expressing | 303 |
J Plouet S Sordello B Malavaud and N Ortega 175 | 360 |
Інші видання - Показати все
Breast Cancer Advances in Biology and Therapeutics Henri Magdelenat Обмежений попередній перегляд - 1996 |
Загальні терміни та фрази
acid adjuvant advanced breast cancer Advances in biology analysis angiogenesis antigen apoptosis aromatase associated binding Biol biology and therapeutics bone marrow BRCA1 breast cancer breast cancer cells breast cancer patients breast cancer screening breast carcinoma Calvo Cancer Res cath-D cathepsin cathepsin D cell lines chemotherapy Clin Oncol clinical combination Crépin cyclophosphamide cytotoxic detected dietary disease docetaxel domain dose doxorubicin drug effect EGFR episialin estrogen expression extracellular fibroblasts fluorouracil gene genetic growth factor hormone replacement therapy human breast cancer inhibition inhibitors invasive John Libbey Eurotext kinase levels Magdelenat malignant mammary tumor mammography median metastasis metastatic metastatic breast cancer mice monoclonal antibodies MUC1 mutations Navelbine oncogenes ovarian overexpression paclitaxel PEA3 peptides plasminogen activator Proc prognostic factors proliferation protein receptor regimens response risk of breast studies surgery survival tamoxifen target Taxotere testing tissue toxicity treatment trial tumor cells uPA-R uPAR VEGF vinorelbine vitro vivo women